ReWalk Robotics Ltd. (NASDAQ:RWLK) Files An 8-K Other Events

ReWalk Robotics Ltd. (NASDAQ:RWLK) Files An 8-K Other Events
Item 8.01 Other Events.

Story continues below

As previously disclosed on a Current Report on Form 8-K filed on May 17, 2016 with the Securities and Exchange Commission (the “SEC”), on May 16, 2016, ReWalk Robotics Ltd. (“we,” “us” or the “Company”) entered into a Research Collaboration Agreement (the “Collaboration Agreement”) and an Exclusive License Agreement (the “License Agreement”) with the President and Fellows of Harvard College (“Harvard”). Under the Collaboration Agreement, the Company and Harvard agree to collaborate on research regarding the development of lightweight “soft suit” exoskeleton system technologies for lower limb disabilities, which are intended to treat stroke, multiple sclerosis, mobility limitations for the elderly and other medical applications. Under the License Agreement, the Company is granted an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight “soft suit” exoskeleton system technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under the parties’ joint research collaboration.

On May 1, 2017, Harvard and the Company entered into Amendment No. 1 to the Collaboration Agreement (the “Collaboration Agreement Amendment”). On April 1, 2018, Harvard and the Company entered into Amendment No. 1 to the License Agreement and Amendment No. 2 to the Collaboration Agreement (the “Joint Amendment”). This Current Report on Form 8-K is being filed with the SEC for the sole purpose of filing the Collaboration Agreement Amendment and Joint Amendment as Exhibits 10.1 and 10.2, respectively.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

* Confidential treatment has been requested for portions of this document. The omitted portions of this document have been filed with the SEC as required by Rule 24b-2 under the Securities Exchange Act of 1934, as amended.

ReWalk Robotics Ltd. Exhibit
EX-10.1 2 f8k062918ex10-1_rewalkrobot.htm AMENDMENT NO. 1 TO THE RESEARCH COLLABORATION AGREEMENT,…
To view the full exhibit click here

About ReWalk Robotics Ltd. (NASDAQ:RWLK)

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement. The Company’s ReWalk designs focus on people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. The Company offers various products, which include ReWalk Personal and ReWalk Rehabilitation. The Company’s ReWalk Personal is designed for use by individuals at home and in their communities, and is custom-fit for each user. The Company’s ReWalk Rehabilitation is designed for the clinical rehabilitation environment where it provides exercise and therapy.

An ad to help with our costs